Table 2 Medications used during the follow-up period, n (%)

From: Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension

 

LS group

LS/HCTZ group

P-value

Ca channel blocker

34 (68)

25 (49)

<0.05

β-Blocker

9 (18)

7 (14)

NS

α-Blocker

3 (6)

1 (2)

NS

Statin

26 (52)

23 (45)

NS

  1. Abbreviations: HCTZ, hydrochlorothiazide; LS, losartan; NS, nonsignificant.
Back to article page